Neuralink expands the range of trials: second person to receive brain chip implant
The U.S. Food and Drug Administration (FDA) has granted permission to Neuralink, a company founded by Elon Musk, to install its brain implant in another person.
This was reported by the Wall Street Journal.
The first human Neuralink implant began to disconnect from the brain, which led to a temporary loss of some functions. To solve this problem, Neuralink plans to install the device’s streams deeper into the brain. This can help to ensure a more stable and efficient connection of the implant to the human brain.
The FDA’s decision to approve a second patient for Neuralink has sparked widespread public debate, but underscores the interest and potential of this technology, as well as the need to improve its safety and efficacy before widespread adoption.
